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LETTERS TO THE EDITORDOSE PULMONARY WEDGE
RESECTION FOR LUNG
CANCER ALWAYS PROVIDE
WORSE SURVIVAL RESULT
THAN SEGMENTECTOMY?
To the Editor:
I read with profound interest the re-
port fromWhitson and colleagues1 as-
sessing the survival benefit of sublobar
resection for invasive adenocarcinoma
with bronchoalveolar (lepidic) fea-
tures. Wedge resection provided less
benefit in both overall survival and
cancer-specific survival than does seg-
mentectomy, which revealed a similar
survival curve to that of lobectomy.
I have a different opinion regarding
excision for these types of adenocarci-
noma—pulmonary wedge resection
with a sufficient surgical margin might
be enough toattaingoodsurvival results.
In cases of segmentectomy for non–
small-cell lung cancer, local recur-
rence developed less frequently in
cases of sufficient distance from the tu-
mor to the surgical margin (margin/tu-
mor diameter ratio exceeding 1).2 In
addition, better survival has been ob-
served in cases of wedge resection
with a sufficient margin than in cases
with an insufficient margin, which is
closely related to presence of isolated
tumor cells at the surgical margin.3
In the case of a small peripheral tu-
mor located at the easy-to-resect re-
gion, as determined using the Lewis
classification,4 both segmentectomy
andwedge resection canprovidea sim-
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518 The Journal of Thoracic and Cbecause the excision can be performed
with a sufficient surgical margin.
It is crucial to reveal the survival re-
sults of excision cases according to the
margin/tumor diameter ratio.
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We appreciate the letter by Dr Sa-
wabata regarding our study,1 and we
are delighted with his thoughtful in-
sights into our results. We appreciate
the viewpoint that there could be
clinical scenarios in which wedge
resection might be an adequate can-
cer operation. The work by Sawa-
bata and colleagues2 investigating
the ratio of tumor margin to tumor
diameter has provided some of these
data.
However, using the data from the
Surveillance, Epidemiology, and End
Results database, we were not able to
calculate this ratio. A clinical role ex-
ists for a less than anatomic resection
in those in whom preserving theardiovascular Surgery c August 2012maximum amount of pulmonary tissue
or in the very frail are paramount con-
cerns. In the setting of adenocarcinoma
with bronchoalveolar features, which
our report addresses,1 wedge resection
might be adequate for those lesions
with pure lepidic growth (adenocarci-
noma in situ). This is a concern for
pure lepidic growth because of spread
along the alveolar planes; however,
the histologic type is rather indolent.
For all other lesions, those with inva-
sive features, our data would support
an anatomic resection. Data from the
new International Association for the
Study of Lung Cancer classification3
should be informative when they are
available.
Our belief, based on our data and
data from others, would be that the
optimal approach for surgical resec-
tion, when possible, would be an an-
atomic resection with a thorough
evaluation of the mediastinal lymph
nodes. We thank the Editor for the
opportunity to reply to Dr Sawabata’s
letter.
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